The shingles vaccine (Shingrix) is recommended as a series of 2 doses. For most adults aged 50 and older, or 19 and older if immunocompromised, the two doses should be given 2 to 6 months apart. Immunocompromised individuals may receive the second dose sooner, about 1 to 2 months after the first. The vaccine provides protection lasting at least 7 years, with no current booster dose recommended for most people.
Key details about shingles shots:
- Routine vaccination for adults 50 years and older involves 2 doses separated by 2 to 6 months.
- For immunocompromised adults (19 and older), 2 doses are given with an interval of 1 to 2 months if needed for quicker protection.
- The vaccine is highly effective, offering more than 90% protection against shingles.
- Protection is sustained for at least 7 years, possibly longer, and a booster is not generally advised at this time.
- The vaccine can be co-administered safely with other adult vaccines such as COVID-19 and flu shots.
This guidance aligns closely with recommendations from the CDC and other health authorities as of late 2024 and 2025.